References
- Abelson M. B., Chambers W. A., Smith L. M. Conjunctival allergen challenge—a clinical approach to studying allergic conjunctivitis. Arch. Ophthalmol. 1990; 108: 85–88
- Abelson M. B., Paradis A., George M. A., Smith L. M., Maguire L., Burns R. Effects of Vasocon-A in the allergen challenge model of acute allergic conjunctivitis. Arch. Ophthalmol. 1990; 108: 520–524
- Bisgaard H., Ford-Hutchinson A. W., Charleson S. Production of peptido-lipid leukotrienes in human tear fluid following antigen challenge. Prostaglandins 1984; 28: 620–622
- Bisgaard J., Ford-Hutchinson A. W., Charleson S., Taudorf E. Detection of leukotriene C4-liked immunoreactivity in tear fluid from subjects challenged with specific allergen. Prostaglandins 1984; 27: 369–374
- Bisgaard J., Ford-Hutchinson A. W., Charleson S., Taudorf E. Production of leukotrienes in human skin and conjunctival mucosa after specific allergen challenge. Allergy 1985; 40: 417–423
- Creticos P. S., Peters S. P., Adkinson N. F., Naclerio R. M., Hayes E. C., Norman P. S., Lichtenstein L. M. Peptide leukotriene release after antigen challenge in patients sensitive to ragweed. N. Engl. J. Med. 1984; 310: 1626–1630
- Friedlaender M. H. Conjunctival provocative tests: A model of human ocular allergy. Tr. Am. Ophthalmol. Soc. 1989; LXXVII: 577–597
- Kari O., Salo O. P., Halmepuro L., Suvilehto K. Tear histamine during allergic conjunctivitis challenge. Graefe's Arch. Clin. Exp. Ophthalmol. 1985; 223: 60–62
- Moller C., Bjorksten B., Nilsson G., Dreborg S. The precision of the conjunctival provocation test. Allergy 1984; 39: 37–41
- Udell I. J., Abelson M. B. Animal and human ocular surface response to a topical nonimmune mast-cell degranulating agent (compound 48/80). Am. J. Ophthalmol. 1981; 91: 226–230
- Beaven M. A. Histamine: Its role in physiological and pathological processes. Monographs in Allergy 1978; 13: 1–113
- Burkhalter A., Frick O. L. Histamine, Serotonin, and the Ergot Alkaloids. Basic and Clinical Pharmacology. Lange Medical Publications, Los Altos, CA 1984
- Miller J., Wolf E. H. Antazoline phosphate and naphazoline hydrochloride singly and in combination for the treatment of allergic conjunctivitis—a controlled, double-blind clinical trial. Ann. Allergy 1975; 35: 81–86
- Ward R. L., Smith J. P. Comfort evaluation of Naphcon-A vs. Albalon-A and Vasocon-A. 1977; 310, Alcon Laboratories Clinical Monitors Report 008:771–07
- Ward R. L., Cagle G. D., Beasley C. H. A comparison of pupillary dilation and conjunctival hyperemia following topical ocular dosing of naphcon-A and albalon-A. 1979, Alcon Laboratories Clinical Monitor's Report 001:3430:0779
- Smith J. P., Lanier B. Q., Tremblay N., Ward R. L., deFaller J. M. Treatment of allergic conjunctivitis with ocular decongestants. Curr. Eye Res. 1982/1983; 2: 141–147
- Abelson M. B., Allansmith M. R., Friedlaender M. H. Effects of topically applied ocular decongestant and antihistamine. Am. J. Ophthalmol. 1980; 90: 245–257
- Fox K., Schneider D., Duckett T. G., Diegel T., Shellenberger K., Akers P., Kuankuan C., Borrman L. A comparison of oxymetazoline with antihistamine-decongestant combination products in noninfectious and allergic conjunctivitis. Ital. J. Ophthalmol. 1988; II/2: 103–107